Loading
Latest filing published 15 Mar 2016 for ImmunoCellular Therapeutics, Ltd..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
David Fractor is a declared insider of ImmunoCellular Therapeutics, Ltd., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 18 February 2015 and the latest from 11 March 2016.
Every open-market trade on record is a purchase: 1 purchase worth €8,768, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.
On 15 March 2016 came the latest disclosure, a share grant in ImmunoCellular Therapeutics, Ltd. The most recent open-market purchase was published on 20 February 2015, 4,264 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations